Trisha Suppes, MD, PhD
Publication Details
-
A placebo-controlled evaluation of adjunctive modafinil in the treatment of bipolar depression.
Am J Psychiatry. 2007; (8): 1242-9
Modafinil is approved by the U.S. Food and Drug Administration for improving wakefulness in patients with excessive sleepiness associated with narcolepsy, obstructive sleep apnea, and shift-work sleep disorder. This study was conducted to evaluate the efficacy and safety of adjunctive modafinil in bipolar depression, which is often characterized by excessive sleepiness and fatigue.
Help